Clinical Trials | February 14, 2024
Roche launches three new Factor Xa inhibitor coagulation tests
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
The new tests can support clinical decision making when prescribing direct oral anticoagulants for stroke prevention
Indian Pharma Post brings together the views of industry leaders on the Interim Union Budget 2024-25 announcement and its impact on the industry
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Collaboration provides AstraZeneca with exclusive rights to Omniose’s proprietary bioconjugation platform to explore potential vaccines for a broad range of bacterial pathogens
The unit’s contribution to the company's revenue US$3.85 million in the last fiscal year
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
KBR will provide outreach, education and data analytics to support critical neuroscience research for the prevention and treatment of military members with CTE
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
Subscribe To Our Newsletter & Stay Updated
